Analyzing
Short summary
To demonstrate this tool, we want to develop a prion detection assay. We decided to use the yeast prion Sup35 as a model protein. During translation of Sup35, two different orthogonal tRNA/aaRS incorporate two different ncAAs which could be labeled specific with fluorophores. For the assay, the labeled test protein is added to a sample. If prions are in that sample they will change the conformation of the test protein. This will result in the change of the fluorescence. If there are no prions in the sample, the fluorescence will stay the same.
Evolved synthetases for the incorporation of propargyllysine and p-acetophenylalanine
We received plasmids from the Lemke group from EMBL in Heidelberg containing an evolved tyrosyl tRNA/ synthtase pair (tRNA/TyrRS) from Methanococcus janashii for the incorporation of AcF and an evolved pyrrolysyl synthetase from Methanosarcina mazei for the incorporation of PrK, both in response to the amber codon. We used Gibson assembly to clone the tRNA/aaRS and the tRNA from these plasmids into pSB1C3 and replaced cutting sites for EcoRI and SpeI with site directed mutagenesis to provide these synthetases for the iGEM community. Furthermore, we changed the anticodon in the tRNA of the TyrRS tRNA to the anticodon for the less used leucine codon, so the the new aaRS incorporates AcF in response to the codon CTA.
Construction of the expression plasmid for the Sup35 test protein
According to our expert Iker Valle Aramburu, the incorporation of two noncanonical amino acids lowers the yield. He recommended us to use only one noncanonical amino acid and one cysteine, which could be labeled in a maleimide coupling reaction. Mukhopadhyay 2006 showed that mutants of Sup35 containing no cysteines are still able to form prions. So we decided to order a gene synthesis of sup35 containing no cysteines.
For our experiments we cloned the gene synthesis of the NM region of Sup35 into pSB1C3 and used site directed mutagenizes to construct the part BBa_K2201231 containing a histag, one amber codon at position 21 and a cysteine codon at position 121. The control BBa_K2201232 contains cysteine codons at positions 21 and 121. In addition, we constructed these three parts also with a T7-promotor and RBS (BBa_K2201331 and BBa_K2201332), for the inducible expression of the Sup35 variants.